Navigation Links
Medacys to Rebrand as EG Asia; Driving Localization Strategy of EG-GILERO

EG-GILERO, a leader for design, development and contract manufacturing services within the medical device, drug delivery device, and primary pharmaceutical packaging markets, announces today at the MD&M East 2016 Exposition in New York, NY, a major expanded investment in the state-of-the-art Shenzhen, China facility previously branded under Medacys.

"China is encouraging local R&D and local manufacturing, particularly on high-value medical products such as drug delivery and medical devices”, said Larry Jutte, President & COO of EG Industries, “not just to be a supplier of components to the device world, but to be a manufacturer of finished devices for the local market."

With 60,000+ square feet of product design & development resources, in-house tool building, scientific injection molding capabilities and both automated and manual assembly capabilities, EG Asia is well positioned to provide support for our customers seeking entry in this rapidly growing market. Part of this strategic localization effort includes expansion of capabilities with the addition of Liquid Silicone Rubber (LSR) injection molding and more in the coming months.

“The Chinese medical technology market is expected to grow at double digit rates in the coming years,” explains Tim Hopper, CMO of EG-GILERO. “Our investment in our Shenzhen, China facility will allow us to provide our clients with an outsourced solution that provides an OEM product line to the Chinese market. The facility also provides a responsive, high quality and lower cost option to source tooling, molding and assembly for utilization across the globe at a world-class level.”

EG-GILERO continues executing on its strategy to offer its customers options to commercialize their device domestically in the United States or in a lower-cost country such as China with an unwavering commitment to quality and we will continue to work with our customers to ensure proper representation in other strategic areas of the globe.

EG-GILERO is your single-source, trusted partner for design, development and manufacturing within the medical devices, drug delivery, and primary pharmaceutical packaging markets. With operations in the United States and Asia, EG-GILERO is strategically positioned to provide the value added services our clients require in a competitive, ever-changing global marketplace.

About EG Industries
Since 1981, EG Industries has been manufacturing high quality products and providing value added services for worldwide customer satisfaction. We offer the industry's most disciplined R&D, design, engineering and manufacturing production processes that now supports industries including: automotive, medical, energy and life sciences, as well as consumer and industrial customers.

Read the full story at

Source: PRWeb
Copyright©2016 Vocus, Inc.
All rights reserved

Related biology technology :

1. BioConvergence® Expands Services and Rebrands as Singota™ Solutions
2. OpenSGI Rebrands as BigBear, Inc. and Releases New Data Solution Platform
3. Forest2Market Rebrands to Highlight International Expansion
4. FCI™ Rebrands as AgriBusiness Global™, Relaunches Website to Serve Crop Input Value Chain
5. Leading Big Data Consulting Firm Open Software Integrators Rebrands as Mammoth Data
6. Organic Waste Management Rebrands as Ennovor Biofuels to Help Customers Identify Premium Biofuel Products
7. DryLet Technologies Announces the Rebranding and Launch of Patented ManureMagic™
8. PrecisionAg® Media Releases Complimentary White Paper Outlining Six Hot Trends Driving Precision Farming
9. Next Generation Sequencing Market: Increasing NGS Applications Driving the Market Globally to 2020
10. Global CRISPR Market 2015-2021: New Technology is Driving Growth
11. Minimally Invasive Surgery and Device Innovation Driving Growth in $13 Billion Global Market for Gastrointestinal, Colorectal and other Endoscopy Product Markets
Post Your Comments:
(Date:5/15/2020)... FREDERICK, Md. (PRWEB) , ... ... ... a leading supplier of human mesenchymal stem/stromal cell (hMSC) working cell banks ... RoosterCollect™-EV-CC to enable streamlined and multi-format collection of hMSC-derived extracellular vesicles ...
(Date:5/15/2020)... ... 2020 , ... Sentien Biotechnologies, Inc., a clinical-stage biotechnology company developing novel approaches ... Mr. Ganz will continue to lead Sentien’s Board of Directors, a role he has ... Miller and Sentien’s management team. , Mr. Ganz has more than 30 ...
(Date:5/14/2020)... FRANCISCO (PRWEB) , ... May 13, 2020 , ... ... content hub called Future Lab: Optimizing Workflows in the Life Science Lab ... optimize workflows in their lab, from water purification and liquid handling to contamination ...
(Date:5/5/2020)... ... May 04, 2020 , ... ... for the life sciences industry, today announced that Informa Training Partners, a life ... its name to Red Nucleus Boston, effective immediately. , “The name change solidifies ...
Breaking Biology Technology:
(Date:5/25/2020)... ... 2020 , ... Oxford Nanopore Technologies is in advanced development of a new ... COVID-19. , The LamPORE assay is designed to be rapid, low cost, ... numbers of samples. Hardware and reagents sit outside current, squeezed supply chains for ...
(Date:5/21/2020)... ... May 19, 2020 , ... ... (SaaS) provider of operations management solutions, today introduced BioMed to their award-winning ... cloud-based platform for connecting the people and systems around biomedical engineering to ...
(Date:5/21/2020)... ... May 20, 2020 , ... Law Enforcement has always been a highly stressful ... The positions of these men and women put them constantly in harm’s way both ... precisely. Officers have always had to face very high daily stress. Now, COVID-19 introduces ...
Breaking Biology News(10 mins):